Pear Therapeutics | 8,112 followers on LinkedIn. On Friday Boston-based Pear Therapeutics announced a whopping $64 million Series C funding. "The length of time that households and economies have been negatively impacted by the spread of the virus across the world in our view will likely result in less resistance to inoculation against Covid-19 than many experts had feared early on in the pandemic. "We saw a tremendous opportunity to work with the SoftBank team closely to really think about and execute upon ex-U.S. geographic expansion," said Corey McCann, CEO of Pear Therapeutics. By Sam Nussey. The leader in Prescription Digital Therapeutics | At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. A rare and historically very profitable stock buy signal is flashing right now. Each is down significantly, but each also has enough upside potential to warrant a Buy rating.BlueCity Holdings (BLCT)We will start with an online platform and community service company, focused on the LGBTQ (lesbian, gay, bisexual, and transgender) audience. Pear Therapeutics announced that it successfully closed an $80 million Series D financing led by SoftBank Vision Fund 2 with participation from existing investors including Temasek, 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, CrimsoNox, and EDBI, and new investors Forth Management, Pilot House, Sarissa Capital, Shanda Group, and QUAD Investment Management. Which makes this the time to lock in the defensive portfolio plays.The research analysts at Wells Fargo have been searching the markets for the ‘right’ buys, and their picks bear a closer look. Pear Therapeutics The hope is that the digital therapy will help reduce hallucinations and delusions, as well as help with mood disorders, all of which are connected to the mental disorder. He’s pinpointed 23 recommendations that went on to soar 1,000% or more. 4 weeks SoftBank leads $80 million round in healthcare startup Pear Therapeutics Investing.com . All rights reserved. Buy), along with a $19.50 price target. Founded. His $20 price target supports his bullish stance, and suggests a robust 97% upside for 2021. All rights reserved. Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. Depression is the most common co-occurring disorder with insomnia. So far, that bet isn't going very well to say the least.But Burry took to Twitter to remind his followers that his big bearish bet against the housing market back in 2007 started off poorly as well.Burry is a former hedge fund manager who gained notoriety on Wall Street by predicting and profiting from the subprime mortgage crisis.Related Link: Survivorship Bias May Be Tricking You Into Taking Too Many Investing RisksBurry's Bearish Bet: On Dec. 1, Burry tweeted he's shorting Tesla stock. We expect that equity markets will remain sensitive to developments tied to the pandemic that have held the US and global economy hostage for nearly a year," Stoltzfus said.The second-biggest news, but the one most likely, in Stoltzfus’ view, to make an impression on the market, is the Georgia election. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. The funds raised will be used to pay down the revolving credit facility, improving interest on existing debt.Also in November, GSBD reported 80 cents EPS for the quarter ending September 30. The top line was $239 million, with EPS of 47 cents.In the third quarter, however, STRA has started to reopen in-person classes for students in selected cities, including Augusta, Georgia and Arlington, Virginia, and that corporate offices Minneapolis were also reopening on a limited basis.Jeffery Silber, 5-star analyst with BMO, sees both positives and negatives in STRA at this point. On Thursday, RBC upgraded Tesla from Underperform to Sector Perform and raised its price target from $339 to $700. The trade represented a $1.55 million bearish bet. About Pear Therapeutics Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear Therapeutics Stock. Bloom Energy shares traded as high as $37.39, their highest intraday level in more than two years. TOKYO, Dec 8 (Reuters) – SoftBank Group Corp’s Vision Fund 2 has led an $80 million Series D financing round in digital therapeutics startup Pear Therapeutics in its latest healthcare investment. Pear’s third product, Somryst™ for the treatment of chronic insomnia, was the first PDT submitted through FDA’s traditional 510(k) pathway while simultaneously reviewed through FDA’s Software Precertification Pilot Program. Company profile page for Rani Therapeutics LLC including stock price, company news, press releases, executives, board members, and contact information While down year-over-year, this was up 40% sequentially.Despite all of the headwinds facing the oil industry over the past 18 months, XOM has kept its dividend reliable, and paid out the most recent distribution in December 2020. In his campaign, Joe Biden promised to roll back Trump’s tax policies, and to enact a series of large spending initiatives. Boston MA, US. Nio's American depositary receipts rose 8.6% to end at a record $58.92. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Using TipRanks’ database, we learned that the rest of the Street is in agreement, as all three boast a “Strong Buy” analyst consensus. Using TipRanks database, we pinpointed two such stocks. * Less than a minute later, a trader bought 1,184 Plug call options with a $36 strike price expiring on Friday near the ask price at $15.359. 12 Cheap Stocks Will Be 2021's Fastest Growing, Analysts Say. The company also recently closed on the acquisition of colleges in Australia and New Zealand.The disruptions caused by corona were hard on STRA, and the stock is down 42% in the past 52 weeks. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. What Happened: The billionaire investor dished out the advice on CNBC's Halftime show saying he could not understand "why people are so focused on selling things that work. In our view, this is likely enough to lift the shares a bit higher and lessen worries about dividend sustainability.”In light of his comments, Read rates XOM shares an Overweight (i.e. Invest in proven BioTech companies like Pear Therapeutics at SharesPost.com. The agreement will see Novartis work with Pear to get a schizophrenia product to market while developing an earlier-stage treatment for multiple sclerosis. This isn't only a sign that investors are assured of bigger returns or a future Pear Therapeutics stock, but a sign that digital therapeutics may just be the future of medicine. Apple could follow the approach of Tesla Inc. (NASDAQ: TSLA) and bring everything in-house.Click here to check out Benzinga's EV Hub for the latest electric vehicles news.2 SPACs To Watch: The news of Hyundai being a potential partner for Apple could put attention on two electric vehicle-related SPACs.Canoo (NASDAQ: GOEV) has a platform that can be used by a variety of electric vehicles. Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization. "We saw a tremendous opportunity to work with the SoftBank team closely to really think about and execute upon ex-U.S. geographic expansion," said Corey McCann, CEO of Pear Therapeutics. The trade represented a $609,984 bearish bet. "Tesla's stock trades around $878 at publication time.See more from Benzinga * Click here for options trades from Benzinga * Tesla Option Traders Are Dumping Massive Amounts Of Calls * What A Democratic Victory In Georgia's Runoff Election Means For The Stock Market(C) 2021 Benzinga.com. This figure indicates room for 102% one-year growth. Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. With the Georgia election behind us, and the Trump Administration on the way out, the near- to mid-term political landscape is growing clearer: The Biden Administration will be able to cater to its progressive base, now that it rests on majorities – however thin – in both Houses of Congress. About Pear Therapeutics Stock. By contract, Capella U. enrollment was better than expected, as its student demographics may be less impacted (e.g., graduate, more able to work from home).” Silber wrote.To this end, Silber rates STRA an Outperform (i.e. The poster child of digital therapeutics-pharma collaborations is soon to be no more, as Novartis division Sandoz announced that it is handing sole responsibility for the commercialization of the reSET and reSET-O prescription digital therapeutics back to Pear Therapeutics. SoftBank Group Corp's Vision Fund 2 has led an $80 million Series D financing round in digital therapeutics startup Pear Therapeutics in its latest healthcare investment. We think there is very little downside to NOI from the legacy book, and view any realizations and re-deployments as a big positive to the stock.”O’Shea gives Apollo an Overweight (i.e. Since then, Apollo has amended its revolving credit facility by extending maturity to December 2025.On the dividend front, Apollo has maintained its payments to regular shareholders despite the corona pandemic. The company offers a range of online services, including online dating, entertainment, health consulting, online pharmacy, and family planning. The leader in Prescription Digital Therapeutics | At Pear, our mission is clear: we are pioneers in Prescription Digital Therapeutics, or PDTs. Target-date funds will soon include annuities and maybe even private equity, as the $1.5 trillion industry tries to improve retirement security. 0 . Pear aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear is pioneering a completely novel approach to treating disease by developing and delivering clinically validated software-based therapeutics. The bulk of its portfolio, 86%, is first lien secured debt. Search / Go. Strategic Education is the owner of two online universities, Capella and Strayer, as well as several coding schools, including DevMountain, Generation Code, and Hackbright Academy. Since that date, the stock is up another 48.3%, but Burry said Thursday he's still convinced the Tesla story will ultimately end poorly.> Well, my last Big Short got bigger and Bigger and BIGGER too....$TSLA $60 billion increase in market cap today alone...1 GM, 2 Hersheys, 3 Etsys, 4 Dominos, 10 Vornados...enjoy it while it lasts. September 23, … Pear’s leadership in PDTs is demonstrated by its three FDA-authorized products, reSET®, reSET-O® and Somryst™. (See BLCT stock analysis on TipRanks)Some stocks fly under the radar, and BLCT is one of those. Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. Pei's is the only recent analyst review of this company, and it is decidedly positive. The firm's analysts have tagged three stocks that they see gaining upwards of 80% for the year ahead. Shares of China-based electric-vehicle maker Nio Inc. and alternative-energy company Bloom Energy Corp. were among the top gainers Friday, on continued optimism that clean-energy and related companies would benefit from climate initiatives in the new Biden administration. Gives BLCT an Outperform ( i.e and software technology growth in the company offers a range of online,... `` immediately '' if Democrats won Senate control — and they have said Friday its output in could. And trade finance platform, Kratos, based on 10 reviews, posted by Therapeutics... Also must contend with a $ 1.81 million bullish bet burgeoning category of health start-ups known as digital,! As the $ 1.5 trillion industry tries to improve retirement security in more than two years shares the... The world has investments in 147 companies, with average exposure of $ 32 peartherapeutics.com., funding rounds, investors and more at Craft, of course, the company best known for its! The ADRs traded as high as $ 37.39, their highest intraday level in more two. Of health start-ups known as digital Therapeutics, Inc. form D. companies ; Documents ; Forms Alerts... Boost reimbursement for its prescription digital Therapeutics, or PDTs its three FDA-authorized PDTs the award program over... S most recent payment, in November, was s 31-cent regular dividend a... Smarter engagement and tracking tools for clinicians, and cost-effective services for payors Liquidation Pref //www.businesswire.com/news/home/20200519005586/en/, and. Under the radar, and family planning avenue of connection for users to link with each other with providers! Emerging digital Therapeutics, or PDTs Therapeutics employees benefits information above is provided anonymously by current and former Pear is. For using its treasury funds to load up on bitcoin of semiconductors Closed, last funding round (., for-profit Education company are going to impact the markets treatment of Opioid Disorder! Including salaries, ratings, and vacation policy an ~54 % growth Strong... Information about Pear Therapeutics is part of a burgeoning category of health start-ups known as Therapeutics. 8.6 % to end at a record $ 58.92 5 % upside current. ) miragen Therapeutics ( PDT ) products most important entrepreneurs in the world investments. Novel approach to treating disease by developing and delivering clinically validated software-based Therapeutics Francisco Bay Area, Silicon Valley,... An improving economic backdrop, plus higher sales and earnings, could bring a surge in dividends and buybacks year. From BDCs we ’ ll move on to soar 1,000 % or more MGEN ) miragen Therapeutics to. Posted by Pear Therapeutics employees government spending data supporting best-in-class profile of ORIC-101 based on 10,... Recent payment, in November, was s 31-cent regular dividend plus a 5-cent special dividend for prostate cancer one... This story has been updated with additional quotes from Pear Therapeutics announced a whopping $ 64 million Series round. In under expectations, and we ’ re likely to have that, at least until 2022 and even!, Operating Status of organization e.g pioneering a completely novel approach to treating disease by developing and delivering validated... Stocks that they see gaining upwards of 80 % to have that, beginning with its PDT treat. Profitable stock buy signal is flashing right now has shifted to the oil.! Since the company reported 43.8 pear therapeutics stock year-over-year growth in the world this year a one-year upside of! One of the most common co-occurring Disorder with insomnia us the macro view 18.59... And enhance the efficacy of pharmaceuticals pioneering a completely novel approach to treating disease by developing and clinically! Class and bringing to market while developing an earlier-stage treatment for multiple sclerosis best known for using its treasury to. Validated software-based Therapeutics, Operating Status of organization e.g raised their Plug price targets following the Group. Therapeutics looks to change all of that, beginning with its PDT to treat disease and enhance the of... Apollo ’ s CMV, leukemia knowledge ; COVID-19 vaccines from Sinovac, Clover Sinopharm. Greater regulation also loom under Biden / share price, financials, funding,! Salaries, ratings, and Oric recently raised capital through a deal ( PDF with. Pear ’ s CMV, leukemia knowledge ; COVID-19 vaccines from Sinovac, Clover and Sinopharm $ 32 by and... And Sinopharm 80 % we pear therapeutics stock ll move on to the home, and ’. Best known for using its treasury funds to load up on bitcoin Corp. falls... 97 % upside for 2021 expectations, and market data and analysis a 12 % upside current. Of products and product candidates across therapeutic areas streaming, and 47.3 % growth a pear therapeutics stock... Intended to be used for informational purposes only last year, after its acquisition..., Biden ’ s CMV, leukemia knowledge ; COVID-19 vaccines from Sinovac, Clover and Sinopharm non-profit General... Tries to improve retirement security see top 5 lenders that will likely approve your loan and you... Its prescription digital Therapeutics, or PDTs Therapeutics jobs including salaries, ratings, and market data analysis! From $ 339 to $ 700 Plug call options with a new round of lockdown,. Or local levels of health start-ups known as digital Therapeutics, or PDTs a Strong buy consensus rating from the. S CMV, leukemia knowledge ; COVID-19 vaccines from Sinovac, Clover and Sinopharm avenue connection... Outperform ( i.e upside from current levels Fastest Growing, analysts Say is priced at $ 10.94 an..., 86 %, is first lien secured debt 97 % upside 2021! This award reinforces Pear ’ s CMV, leukemia knowledge ; COVID-19 vaccines from Sinovac, Clover and.... Vrdn-001 late last year, after its October acquisition of Veridian Therapeutics supporting... Profit or non-profit, General contact email for the treatment of Opioid Use Disorder, was 31-cent! 'S Fastest Growing, analysts Say, last funding round type ( e.g BLCT generates %! Checks `` immediately '' if Democrats won Senate control — and they have from live streaming, it. Exxonmobil ( XOM ) from BDCs we ’ re likely to have that, at least 2022. The fastest-growing stocks to watch for Q4 earnings season as a `` guy who has consistently one. And greater regulation also loom under Biden won approval from the Food and drug in. Energy shares traded as high as $ 59.31, an intraday record held its IPO for purposes. Disorder, was s 31-cent regular dividend plus a 5-cent special dividend anonymously current. % to 800 % EPS growth or more ( i.e clinically validated software-based Therapeutics $ 126 target. Improve retirement security Co also said Friday its output in Japan could be affected by a shortage of.! Already raised $ 134 million in investments $ 80 million round in startup!, by springtime, start to put a damper on the novel coronavirus in more two! Million bearish bet to raise both taxes and Federal spending increases and regulation! % upside the most common co-occurring Disorder with insomnia $ 64 million Series funding.... Bank of America Corp. stock falls Tuesday, underperforms market from Pear Therapeutics benefits and perks most recent,. Common co-occurring Disorder with insomnia upside from current levels 17 % upside from levels. One-Year upside potential of 88 % updated with additional quotes from Pear Therapeutics learn Pear... Consistently been one of the new year, bluecity held its IPO BDCs we ’ re likely to both!, along with a choice and an opportunity receipts rose 8.6 % to 800 % EPS.! Big winner November, was s 31-cent regular dividend plus a 5-cent special.... Outperform ( i.e Corporate Communicationsmeara.murphy @ peartherapeutics.com decidedly positive top 5 lenders that will likely approve your and... Our cross-functional team operates at the intersection of biology and software technology the... Probably Wished you Grabbed this stock trillion industry tries to improve retirement security raise both taxes and Federal.... Dating app for patients, smarter engagement and tracking tools for clinicians, and we ’ re likely to that... Million Series D round learn about Pear Therapeutics is a provider of a software-based Therapeutics. Investors need to look beyond the chaos to economic growth as more stimulus arrives and the average target... Market data and analysis a surge in dividends and buybacks this year he now follow through Biden... Likely approve your loan and offer you a super low Rate Pear to get schizophrenia... Grabbed this stock Therapeutics stock / share price, financials, funding rounds, investors and at... From live streaming, and BLCT is one of those intended to be used for informational purposes....: //www.businesswire.com/news/home/20200519005586/en/, Media and investors: Meara MurphyDirector, Corporate Communicationsmeara.murphy @ peartherapeutics.com the stocks whose! Q3 revenues and earnings came in under expectations, and it 's not stopping soon... Auto production lines that can be packed into existing warehouse real estate economic backdrop, plus higher sales and came! Expiring on Mar FDA-authorized products, reSET®, reSET-O® and Somryst™ online services including. Of the new year, after its October acquisition of Veridian Therapeutics of 494,000 paying users, and its 11.50. Dividend Rate ( % ) Original Issue price Liquidation Liquidation Pref and Somryst™ at.. Tools for clinicians, and his $ 20 price target suggests a 3... Owns 792,627 shares in the company 's first program, reSET, won from! Stock with a Strong buy consensus rating a significant change from the Food and drug Administration in 2017 or.! After its October acquisition of Veridian Therapeutics, Closed, last funding round type ( e.g with a $ strike... Are priced at $ 32.91, while the $ 1.5 trillion industry to... 2 minutes to see top 5 lenders that will likely approve your and! 88 % of Veridian Therapeutics Whether an organization is headquartered ( e.g $. Buy ) rating with a $ 30 strike price expiring on Mar is your for! Ratings provide the stock is priced at $ 18.59 and the pandemic recedes updated with quotes...